dos Santos Silva I. Cancer epidemiology: principles and methods. Lyon France: World Health Organization. International Agency for Research on Cancer; 1999. p. 385-403.
Institute of Oncology Ljubljana. Cancer Registry of Republic of Slovenia and other registries. [cited 2021 Sep 15]. Available at https://www.onko-i.si/eng/sectors/epidemiology-and-cancer-registry
Zadnik V, Žagar T, Lokar K, Tomšič, Duratović Konjević A, Bric N, et al. [Survival of cancer patients in Slovenia.] [Slovenian]. Onkologija 2021; 25: 42-7. doi: 10.25670/oi2021-004on
Hočevar M. [Clinical registry in oncology]. [Slovenian]. Onkologija 2011; 15: 14-7. [cited 2021 Aug 15]. Available at http://www.dlib.si/?URN=URN:NBN:SI:doc-YC5I34R6
Takač I, Ferletič M, Arko D, Gorišek B. [Follow-up computer program for patients with ovarian malignancy]. [Slovenian]. Bigec M, Lavrenčič D, Kokol P, editors. Proceedings part II. Inform Med Slov 1996; 3: 43-6.
Takač I, Gorišek B. User friendly inquiry and computer program for following patients with ovarian malignancy. Arch Gynecol Obstet 1999; 263: 60-7. doi: 10.1007/s004040050264
Arko D, Takač I. Inquiry and computer program Onko-Online: 25 years of clinical registry for breast cancer at the University Medical Centre Maribor. Radiol Oncol 2019; 53: 348-56. doi: 10.2478/raon-2019-0043
Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359: 1093-101. doi: 10.1016/S0140-6736(02)08151-5
The International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007; 120: 885-91. doi: 10.1002/ijc.22357
Trimble CL, Genkinger JM, Burke AE, Hoffman SC, Helzlsouer KJ, Diener-West M, et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol 2005; 105: 174-81. doi: 10.1097/01.AOG.0000148268.43584.03
Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric casecontrol study. Lancet 2002; 359: 1085-92. doi: 10.1016/S0140-6736(02)08150-3
Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L. Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis. Cancer 2006; 106: 664-9. doi: 10.1002/cncr.21660
Kesic V, Poljak M, Rogovskaya S. Cervical cancer burden and prevention activities in Europe. Cancer Epidemiol Biomarkers Prev 2012; 21: 1423-33. doi: 10.1158/1055-9965.EPI-12-0181
Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control 2009; 20: 1129-38. doi: 10.1007/s10552-009-9317-z
Gutnik H, Kastelic P, Oštrbenk Valenčak A, Poljak M, Strojan Fležar M. Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features. Virchows Archiv 2020; 476: 25160. doi: 10.1007/s00428-019-02694-7
Škamperle M, Kocjan BJ, Maver PJ, Seme K, Poljak M. Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe. Acta Dermatovenerol Pannonica Adriat 2013; 22: 1-5. doi: 10.2478/v10162-012-0024-1
Arbyn M, Gultekin M, Morice P, Nieminen P, Cruickshank M, Poortmans P, et al. The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer 2021; 148: 277-84. doi: 10.1002/ijc.33189
Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. doi: 10.1515/raon-2017-0008
Zadnik V, Žagar T. SLORA: Slovenia and cancer. Epidemiology and Cancer Registry. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana. [2021 Feb 14]. Available at: www.slora.si
Lim AWW, Forbes LJL, Rosenthal AN, Raju KS, Ramirez AJ. Measuring the nature and duration of symptoms of cervical cancer in young women: developing an interview-based approach. BMC Womens Health 2013; 13: 45. doi: 10.1186/1472-6874-13-45
Ursic-Vrscaj M, Rakar S, Mozina A, Takac I, Bebar S, Subic Z, et al. Clinical audit of patients with cervical cancer in Slovenia. Data analysis from 20032006. Eur J Gynaecol Oncol 2008; 29: 628-2. PMID: 19115692
Ursic-Vrscaj M, Rakar S, Možina A, Kobal B, Takač I, Deisinger I, et al. [Guidelines for management of women with cervical precancerous lesions]. [Slovenian]. In: Ursic-Vrscaj M, editor. Ljubljana: Institute of Oncology Ljubljana; 2011
Ivanuš U. Colposcopy in the ZORA program. [Slovenian]. In: Smrkolj Š, editor. Refresing colposcopic course. Proceedings. Ljubljana: Association for Gynecologic Oncology, Colposcopy and Cervical Pathology, Slovenian Medical Association, Institute of Oncology Ljubljana; 2019. p. 30-49.
Učakar V, Poljak M, Klavs I. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study. Vaccine 2012; 30: 116-20. doi: 10.1016/j.vaccine.2011.10.066
Vrtačnik Bokal E, Kocjan BJ, Poljak M, Bogovac Ž, Jančar N. Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. J Obstet Gynaecol Res 2010; 36: 1204-13. doi: 10.1111/j.1447-0756.2010.01316.x
Ivanus U, Jerman T, Repse Fokter A, Takac I, Kloboves Prevodnik V, Marcec M, et al. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. Radiol Oncol 2018; 52: 399-412. doi: 10.2478/raon-2018-0036
Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 2009; 105: 107-8. doi: 10.1016/j.ijgo.2009.02.009
Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 2019; 145: 129-35. doi: 10.1002/ijgo.12749
Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991; 20: 667-76. doi: 10.1016/0360-3016(91)90007-q
Espenel S, Garcia MA, Langrand-Escure J, Vallard A, Chloé Trone J, Rancoule C, et al. Special focus on stage IV cervical cancer patients: a decade experience. Oncology 2019; 97: 125-34. doi: 10.1159/000500025
Hallquist Everhov Å, Nyberg T, Bergmark K, Citarella A, Flöter Rådestad A, Lindén Hirschberg A, et al. Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study. Menopause 2015; 22: 633-9. doi: 10.1097/GME.0000000000000357
Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, et al. International endocervical adenocarcinoma criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol 2018; 42: 214-26. doi: 10.1097/PAS.0000000000000986
Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology / European Society for Radiotherapy and Oncology / European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol 2018; 127: 404-16. doi: 10.1016/j.radonc.2018.03.003
Kern I, Strojan Fležar M, Kavalar R, Repše Fokter A, Balažic J, Frković Grazio S. [Guidelines for standardization of procedures and histopathological findings in the field of gynecological pathology ‒ cervical neoplasia]. [Slovenian]. Strojan Fležar M, Frković Grazio S, Gutnik H, editors. Ljubljana: Association for Pathology and Forensic Medicine, Slovenian Medical Association; 2015. [cited 2021 Jul 15]. Available at: https://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/HISTO_smernice_ZPSM-SM-GIN-01_nov2015.pdf
Šegedin B, Sebastjan Merlo S, Arko D, Bebar S, Cerar O, Cvjetićanin B, et al. [Recommendations for the treatment of patients with cervical cancer]. [Slovenian]. In: Šegedin B, Merlo S, editors. Ljubljana: National Program ZORA, Association for Radiotherapy and Oncology, Section for Internal Medicine Oncology, Association fo r Gynecological Oncology, Colposcopy and Cervical Pathology, Slovenian Medical Association, Institute of Oncology Ljubljana; 2019
Bielska-Lasota M, Rossi S, Krzyżak M, Haelens A, Domenic A, De Angelis R, et al. EUROCARE-5 Working Group. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet 2020; 301: 591-602. doi: 10.1007/s00404-019-05412-5
Elit L, Fyles AW, Devries MC, Oliver TK, Fung-Kee-Fung M. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol 2009; 114: 528-35. doi: 10.1016/j.ygyno.2009.06.001
European Medicines Agency. The Cross-Committee Task Force on Patient Registries. Discussion paper: Use of patient disease registries for regulatory purposes – methodological and operational considerations. 5 November 2018. EMA/763513/2018
Wordl Health Organization. Cervical Cancer Elimemination Initiative. [cited 2021 Jun 15]. Available at: https://www.who.int/initiatives/cervical-cancer-elimination-initiative